Dr. Stephen Russell
It's been five years since Stacy Erholtz's original virotherapy treatment. Her nickname in support groups is 'The Measles Lady.' Last summer, the oldest of [...]
ROCHESTER Minn. – Mayo Clinic today announced that fundraising associated with the VICE documentary “Killing Cancer,” which aired on HBO earlier this year, has exceeded $2 million. This achievement was reached a month earlier than anticipated. The Killing Cancer campaign also set a record at Mayo Clinic with 30 percent of gifts received online, compared to 10 percent for previous campaigns. Many of the gifts came from new supporters to Mayo Clinic a reflection the younger demographics of the VICE audience and VICE’s strong digital presence. “The money raised in the Killing Cancer campaign will have impact right away, helping advance cancer research and finding cures for patients,” said John Noseworthy, M.D., Mayo Clinic president and CEO.
The success of the campaign was due in large part to a fundraising match challenge issued by VICE founder and CEO Shane Smith with a total goal of $2 million. Through the challenge, Mr. Smith matched the first $1 million in gifts made by more than 10,000 documentary viewers and loyal Mayo Clinic supporters.
MEDIA CONTACT: Joe Dangor, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu
Following recent outbreaks, we've been hearing a lot about the measles. But in this Mayo Clinic Radio Health Minute, something you may not [...]
We're taking a look back at some of the important medical news of 2014! This Saturday, December 20, at 9 a.m. CT, w
This week we rebroadcast a conversation with two of our favorite guests this year - Stacy Erholtz and Stephen Russell, M.D.. Stacy's been [...]
On Saturday, November 29, at 9 a.m. CT, we’ll rebroadcast a conversation with two of our favorite guests this year - Stacy Erholtz and Stephen Russell, M.D.. Stacy's been involved in groundbreaking research at Mayo Clinic led by Dr. Russell, which uses the measles virus to fight cancer. Stacy shares her story about receiving 10 million doses – a seemingly lethal amount – of the measles virus to treat her multiple myeloma. It's called oncolytic virotherapy, and Dr. Russell discusses the science behind virus therapy. He talks about where future research might be headed, are there other diseases that could be cured by using viruses and where did all those doses of measles vaccine come from? Join us. WATCH this video to learn more: https://www.youtube.com/watch?v=LImk-KdMT1w Follow #MayoClinicRadio and tweet your questions. To listen to the program on Saturday, click here. Mayo Clinic Radio is available on iHeart Radio. Listen to this week’s Medical News Headlines: News Segment November 29, 2014 (right click MP3)
On Saturday, July 12, at 9 a.m. CT, we’ll talk about the groundbreaking research involving the measles virus to fight cancer. The process is called oncolytic virotherapy and Dr. Stephen Russell will be our guest, along with his patient Stacy Erholtz who received 10 million doses – a seemingly lethal amount – of the measles virus to treat her multiple myeloma. The Wall Street Journal article on Health Trackers is found here. WATCH this video: https://www.youtube.com/watch?v=LImk-KdMT1w This Saturday we’ll hear more about Stacy’s amazing story, discuss with Dr. Russell the science behind virus therapy and learn where future research might be headed. Are there other diseases that could be cured by using viruses? Where did all those doses of measles vaccine come from? It’s a remarkable development in the future of medicine. Join us. To listen to the program on Saturday, click here. More information about Living Organ Donation can be found here. The Living Donor Evaluation Form can be found here. The Mayo Transplant Center can be reached at 866-227-1569 Mayo Clinic Radio is available on iHeart Radio. Listen to this week’s Medical News Headlines: News Segment July 12, 2014 (right click MP3)
Many viruses are drawn to cancer like iron filings to a magnet. Why not put these viruses to use — finding, infecting and killing cancer [...]